NEWARK, DE — The global endoscopic vessel harvesting system market is entering a growth phase, projected to expand from USD 603.7 million in 2026 to USD 993.4 million by 2036, registering a CAGR of 5.1%, according to Future Market Insights (FMI). Market growth is being fueled by increasing adoption of minimally invasive coronary artery bypass grafting (CABG) procedures, rising prevalence of cardiovascular diseases, and healthcare infrastructure development in key regions.

Endoscopic vessel harvesting systems facilitate precise and minimally invasive collection of saphenous veins and radial arteries, enhancing patient outcomes, reducing surgical trauma, and improving graft quality during cardiovascular surgeries. Hospitals, ambulatory surgical centers, and specialty clinics are increasingly deploying these systems to meet procedural efficiency and patient safety requirements.

Endoscopic Vessel Harvesting System Market Quick Stats Snapshot:

• 2026 Market Value: USD 603.7 Million
• 2036 Forecast Value: USD 993.4 Million
• CAGR (2026–2036): 5.1%
• Leading Product Segment: Disposable Systems (65% share)
• Leading Vessel Type: Saphenous Vein (70% share)
• Key Growth Driver: Adoption of minimally invasive CABG procedures
• Top Players: Getinge AB, Terumo Corporation, LivaNova PLC, KARL STORZ SE & Co., Saphena Medical Inc.

Market Momentum: Minimally Invasive Surgery Driving Adoption

Rising cardiovascular disease prevalence and an aging population are accelerating demand for advanced surgical technologies. Minimally invasive vessel harvesting procedures improve graft success rates and reduce patient recovery times, supporting widespread adoption in developed and emerging healthcare markets. Disposable systems are preferred for sterility and workflow efficiency, while saphenous vein harvesting remains the dominant vessel type due to anatomical and clinical advantages.

Segment Insights:

Product Leadership

• Disposable systems dominate due to infection control and streamlined surgical workflow benefits
• Reusable systems maintain demand in cost-sensitive facilities

Vessel Type Leadership

• Saphenous vein harvesting leads the market (70% share), widely used in CABG procedures
• Radial artery harvesting caters to specialized applications

End-User Dominance

• Hospitals lead deployment with centralized procurement and high surgical volumes
• Ambulatory surgical centers and specialty clinics see growing adoption

Regional Insights:

• United States: Largest market, driven by advanced cardiac surgery infrastructure and adoption of minimally invasive procedures
• Germany: Strong growth through precision engineering and quality healthcare standards
• Japan: High CAGR (4.6%) due to aging population and surgical innovation
• India & Brazil: Emerging markets expanding via healthcare infrastructure and cardiovascular awareness programs

Competitive Landscape: Innovation and Collaboration at Core

The market is moderately consolidated, with key players leveraging product innovation, global distribution, and training programs. Strategies include developing advanced ergonomics, AI-enabled platforms, and disposable system solutions.

Leading Players:

• Getinge AB
• Terumo Corporation
• LivaNova PLC
• KARL STORZ SE & Co.
• Saphena Medical Inc.

Key Growth Drivers and Challenges:

Growth Drivers:

• Rising cardiovascular disease prevalence
• Adoption of minimally invasive surgical procedures
• Technological advancements in harvesting systems

Challenges:

• High cost of systems
• Regulatory approval and training requirements
• Integration complexities in procedural workflows

Strategic Takeaways for Decision Makers:

• Expand in high-growth markets like India, Japan, and Brazil
• Invest in disposable and AI-enhanced systems to improve procedural efficiency
• Strengthen hospital partnerships to drive adoption and training

Request Sample Report | Customize Report | Purchase Full Report:https://www.futuremarketinsights.com/reports/sample/rep-gb-1620

Why This Market Matters Now

With cardiovascular diseases on the rise and surgical techniques evolving toward minimally invasive approaches, endoscopic vessel harvesting systems are becoming essential to modern cardiac surgery. Hospitals and specialty clinics benefit from improved patient outcomes, reduced procedural trauma, and operational efficiency.

Frequently Asked Questions (FAQ)

How big is the market in 2026? USD 603.7 million
What is the 2036 forecast? USD 993.4 million
What is the growth rate? 5.1% CAGR (2026–2036)
Which product type leads? Disposable systems (65% share)
Which vessel type dominates? Saphenous vein (70% share)
Who are the major players? Getinge AB, Terumo Corporation, LivaNova PLC, KARL STORZ SE & Co., Saphena Medical Inc.

 Explore More Related Studies Published by FMI Research:

Intelligent Prosthetics Market-https://www.futuremarketinsights.com/reports/intelligent-prosthetics-market

Cell Therapy Manufacturing Market-https://www.futuremarketinsights.com/reports/cell-therapy-manufacturing-market

Ambulatory Polysomnography (PSG) Systems Market-https://www.futuremarketinsights.com/reports/ambulatory-polysomnography-psg-systems-market

Drug Formulation Market-https://www.futuremarketinsights.com/reports/drug-formulation-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Contact Us:    

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com